ReviewBritish journal of cancer2020

Patient-derived explants (PDEs) as a powerful preclinical platform for anti-cancer drug and biomarker discovery.

Ian R Powley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.